Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Mallinckrodt
Merck
McKinsey
Johnson and Johnson

Last Updated: January 25, 2022

DrugPatentWatch Database Preview

Investigational Drug Information for AZD1775


Email this page to a colleague

« Back to Dashboard

What is the development status for investigational drug AZD1775?

AZD1775 is an investigational drug.

There have been 54 clinical trials for AZD1775. The most recent clinical trial was a Phase 2 trial, which was initiated on March 1st 2014.

The most common disease conditions in clinical trials are Neoplasms, Carcinoma, and Lung Neoplasms. The leading clinical trial sponsors are AstraZeneca, National Cancer Institute (NCI), and Parexel.

There are thirty US patents protecting this investigational drug and three hundred and forty-seven international patents.

Recent Clinical Trials for AZD1775
TitleSponsorPhase
Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]AdavosertibParexelPhase 1
Human Absorption, Distribution, Metabolism, and Excretion Study of [14C]AdavosertibAstraZenecaPhase 1
A Study to Assess the Safety and Tolerability of Adavosertib for Patients With Advanced Solid TumoursParexelPhase 1

See all AZD1775 clinical trials

Clinical Trial Summary for AZD1775

Top disease conditions for AZD1775
Top clinical trial sponsors for AZD1775

See all AZD1775 clinical trials

US Patents for AZD1775

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
AZD1775 ⤷  Try it Free Remote loading of sparingly water-soluble drugs into lipid vesicles ZONEONE PHARMA, INC. (San Francisco, CA) ⤷  Try it Free
AZD1775 ⤷  Try it Free Treatment of myelodysplastic syndromes with 2-O and,or 3-O desulfated heparinoids Cantex Pharmaceuticals, Inc. (Weston, FL) ⤷  Try it Free
AZD1775 ⤷  Try it Free Silanol based therapeutic payloads BlinkBio, Inc. (Jupiter, FL) ⤷  Try it Free
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts
Mallinckrodt
Merck
McKinsey
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.